Shares of South Korean pharmaceutical firm TDS Pharm (KOSDAQ:464280) plunged nearly 19% on Thursday after it soared on its debut on the secondary market KOSDAQ on Wednesday.
As of Wednesday morning, stocks were trading at 35,650 won, a 174.23% jump from the offering price of 13,000 won, Pulse News reported Wednesday.
The competition ratio for the bookbuilding session was 1,331.2 to 1, with the offering price exceeding the target range of 9,500 won to 10,700 won. During the public subscription period, the competition ratio was 1,608.17 to 1, it said.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Comments